Xue Jun Song
Corporate Officer/Principal bei Southern University of Science & Technology
Profil
Xue Jun Song is currently the Executive Director of the Pain Medical Centre at Peking University and the Professor & Director of the SUSTech Center at Southern University of Science & Technology.
Mr. Song previously worked as an Independent Non-Executive Director at China Kangda Food Co. Ltd., Associate Director at Parker University, and Associate Director at The Parker Institute For Cancer Immunotherapy.
Mr. Song received a doctorate degree from the Chinese Academy of Sciences in 1995, an undergraduate degree from Xuzhou Medical University in 1986, and a graduate degree from Xuzhou Medical University in 1992.
Aktive Positionen von Xue Jun Song
| Unternehmen | Position | Beginn |
|---|---|---|
| Southern University of Science & Technology | Corporate Officer/Principal | - |
Peking University
 Peking University Other Consumer ServicesConsumer Services Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Xue Jun Song
| Unternehmen | Position | Ende |
|---|---|---|
| CHINA KANGDA FOOD COMPANY LIMITED | Direktor/Vorstandsmitglied | 18.06.2020 |
| Parker University | Corporate Officer/Principal | 01.01.2016 |
The Parker Institute For Cancer Immunotherapy
 The Parker Institute For Cancer Immunotherapy Miscellaneous Commercial ServicesCommercial Services The Parker Institute for Cancer Immunotherapy is a research organization that aims to accelerate the development of breakthrough immune therapies to turn all cancers into curable diseases. The Parker Institute for Cancer Immunotherapy is based in San Francisco, CA. The private company conducts clinical trials to tackle the toughest cancers and answer the hardest questions in immunotherapy. The institute coordinates cancer research efforts between the best scientists, clinicians, and partners in the industry. The company has legal experts who help their researchers navigate the intellectual property process and turn their cancer immunotherapy discoveries into treatments. It was founded by Sean N. Parker, Adam Kolom, Michael Polansky. | Corporate Officer/Principal | 01.01.2003 |
Ausbildung von Xue Jun Song
| Xuzhou Medical University | Undergraduate Degree |
| Chinese Academy of Sciences | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CHINA KANGDA FOOD COMPANY LIMITED | Consumer Non-Durables |
| Private Unternehmen | 1 |
|---|---|
The Parker Institute For Cancer Immunotherapy
The Parker Institute For Cancer Immunotherapy Miscellaneous Commercial ServicesCommercial Services The Parker Institute for Cancer Immunotherapy is a research organization that aims to accelerate the development of breakthrough immune therapies to turn all cancers into curable diseases. The Parker Institute for Cancer Immunotherapy is based in San Francisco, CA. The private company conducts clinical trials to tackle the toughest cancers and answer the hardest questions in immunotherapy. The institute coordinates cancer research efforts between the best scientists, clinicians, and partners in the industry. The company has legal experts who help their researchers navigate the intellectual property process and turn their cancer immunotherapy discoveries into treatments. It was founded by Sean N. Parker, Adam Kolom, Michael Polansky. | Commercial Services |
